224 related articles for article (PubMed ID: 6267464)
1. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
[TBL] [Abstract][Full Text] [Related]
2. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin releasing hormone (GnRH) agonists in male contraception.
Swerdloff RS; Steiner BS; Bhasin S
Med Biol; 1986; 63(5-6):218-24. PubMed ID: 2939304
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
[TBL] [Abstract][Full Text] [Related]
5. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
[TBL] [Abstract][Full Text] [Related]
8. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
10. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
11. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
[TBL] [Abstract][Full Text] [Related]
12. Contraception with LHRH agonists, a new physiological approach.
Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
[TBL] [Abstract][Full Text] [Related]
13. Testicular function after orchiopexy for unilaterally undescended testis.
Lipshultz LI; Caminos-Torres R; Greenspan CS; Snyder PJ
N Engl J Med; 1976 Jul; 295(1):15-8. PubMed ID: 5671
[TBL] [Abstract][Full Text] [Related]
14. Testosterone suppression of the HPT axis.
MacIndoe JH; Perry PJ; Yates WR; Holman TL; Ellingrod VL; Scott SD
J Investig Med; 1997 Oct; 45(8):441-7. PubMed ID: 9394096
[TBL] [Abstract][Full Text] [Related]
15. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
[TBL] [Abstract][Full Text] [Related]
16. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of life.
Liu L; Cristiano AM; Southers JL; Reynolds JC; Bacher J; Brown G; Gilley RM; Tice TR; Banks SM; Loriaux LD
J Clin Endocrinol Metab; 1991 Nov; 73(5):1038-43. PubMed ID: 1939516
[TBL] [Abstract][Full Text] [Related]
17. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
Rösler A; Witztum E
N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644
[TBL] [Abstract][Full Text] [Related]
18. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement.
Vickery BH; McRae GI; Briones W; Worden A; Seidenberg R; Schanbacher BD; Falvo R
J Androl; 1984; 5(1):28-42. PubMed ID: 6231277
[TBL] [Abstract][Full Text] [Related]
19. Inability of continuous long-term administration of D-Nal(2)6-LHRH to abolish fertility in male rats.
Vickery BH; McRae GI; Bergstrom K; Briones W; Worden A; Seidenberg R
J Androl; 1983; 4(4):283-91. PubMed ID: 6225758
[TBL] [Abstract][Full Text] [Related]
20. Treatment of young rams with an agonist of GnRH delays reproductive development.
Tilbrook AJ; Galloway DB; Williams AH; Clarke IJ
Horm Behav; 1993 Mar; 27(1):5-28. PubMed ID: 8440517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]